Former Spark CEO Jeff Marrazzo said hundred of employees caught up in the waves of layoffs will be aided by a network of ...

Read about pharma stocks, CSL, Microbix Biosystems and more in the latest Market Talks covering the Health Care sector.

Of all the countries that expected to be immune to President Trump’s tariffs, Switzerland was at the top of the list. The ...

Switzerland's pharmaceutical industry wants to go green. But new figures reveal that where production happens, the ...

The proportion of foreign nationals in corporate management in Swiss companies “has never been higher", a new report has ...

Trontinemab is currently being studied in the Phase Ib/IIa Brainshuttle AD study assessing the safety, tolerability, ...

A record number of foreign CEOs work at Swiss companies; e-ID will be put to a referendum again and more news in our roundup ...

Roche Holding AG said a high-dose version of Ocrevus, its best-selling multiple sclerosis drug, failed to outperform the ...

The price of West Texas Intermediate, the US benchmark, fell briefly below $60 a barrel, wiping out earlier gains. Brent crude was down 1.5 per cent at $63.26 at four-year lows during afternoon ...

European firms with high US exposure face mounting risks from tariffs, recession fears, and a weakening dollar, while ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...